This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Stocks With Bullish Institutional And Insider Buying Activities

2. Basic Energy Services, Inc. ( BAS, Earnings, Analysts, Financials): Provides a range of well site services to oil and gas drilling and producing companies in the United States. Market cap at $453.2M, most recent closing price at $10.77. Net institutional purchases in the current quarter at 2.9M shares, which represents about 7.79% of the company’s float of 37.22M shares. Over the last six months, insiders were net buyers of 389,570 shares, which represents about 1.05% of the company’s 37.22M share float.

 

3. Genomic Health Inc. ( GHDX, Earnings, Analysts, Financials): Focuses on the development and global commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Market cap at $867.46M, most recent closing price at $28.21. Net institutional purchases in the current quarter at 1.5M shares, which represents about 9.09% of the company’s float of 16.51M shares. Over the last six months, insiders were net buyers of 609,079 shares, which represents about 3.69% of the company’s 16.51M share float.

 

4. Horizon Pharma, Inc. ( HZNP, Earnings, Analysts, Financials): Develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. Market cap at $158.26M, most recent closing price at $2.57. Net institutional purchases in the current quarter at 22.6M shares, which represents about 54.03% of the company’s float of 41.83M shares. Over the last six months, insiders were net buyers of 575,356 shares, which represents about 1.38% of the company’s 41.83M share float.

 

5. Infinity Pharmaceuticals, Inc. ( INFI, Earnings, Analysts, Financials): Engages in the discovery and development of medicines for the treatment of cancer and other conditions in the United States. Market cap at $977.52M, most recent closing price at $24.76.  Net institutional purchases in the current quarter at 8.7M shares, which represents about 39.28% of the company’s float of 22.15M shares. Over the last six months, insiders were net buyers of 5,158,726 shares, which represents about 23.29% of the company’s 22.15M share float.

 

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs